About BDA

Bensinger, DuPont & Associates (BDA) is a national provider dedicated to promoting healthy outcomes for the workplace, employees, individuals and their families. BDA provides employee assistance programs (EAP) and work-life services, training and education, compulsive gambling services, drug testing management and specialized clinical help lines and services.

The Prescription Drug Research Center (PDRC) is a subsidiary of BDA that provides consultation and research to monitor the nonmedical use of specific prescribed controlled substances and to reduce the nonmedical use of these medicines.

Principals and Staff

BDA President and CEO is Peter B. Bensinger, the former Administrator of the U.S. Drug Enforcement Administration and the Illinois Department of Corrections. BDA Executive Vice President and Medical Director is Robert L. DuPont, M.D., the first Director of the U.S. National Institute on Drug Abuse (NIDA), and clinical professor of psychiatry at Georgetown Medical School. He is a national leader in addiction medicine and an expert in prevention and treatment in the workplace. Together, Mr. Bensinger and Dr. DuPont have pioneered efforts to find effective solutions to many important behavioral problems affecting the workplace.

BDA was founded in 1982 to provide Drug-Free Workplace consultation and policy development. BDA began providing EAP services in 1986. Today, BDA provides services that have expanded to support the evolving needs of businesses.

BDA has offices in Chicago, Washington DC, and San Diego along with a nationwide network of providers to provide services to national, regional and local organizations. For more information, visit Contact BDA.